Hailong Sheng

423 total citations
11 papers, 281 citations indexed

About

Hailong Sheng is a scholar working on Molecular Biology, Oncology and Cancer Research. According to data from OpenAlex, Hailong Sheng has authored 11 papers receiving a total of 281 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Molecular Biology, 4 papers in Oncology and 3 papers in Cancer Research. Recurrent topics in Hailong Sheng's work include Cancer Immunotherapy and Biomarkers (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and RNA modifications and cancer (2 papers). Hailong Sheng is often cited by papers focused on Cancer Immunotherapy and Biomarkers (4 papers), Pancreatic and Hepatic Oncology Research (2 papers) and RNA modifications and cancer (2 papers). Hailong Sheng collaborates with scholars based in China. Hailong Sheng's co-authors include Chuanhui Cao, Zhenru Zhu, Yan Huang, Jingyuan Sun, Wanjun Zhang, Jian Wang, Peitao Zhou, Ze-Qin Guo, Hui Wang and Wencong Dai and has published in prestigious journals such as Scientific Reports, Ecotoxicology and Environmental Safety and Radiotherapy and Oncology.

In The Last Decade

Hailong Sheng

8 papers receiving 278 citations

Peers

Hailong Sheng
Zhenru Zhu China
Liangliang Dong China
Chunlai Yin China
Dongzhi Cen China
Yujie Tan China
Zhu Zeng China
Huabin Li China
Yingpeng Zhao China
Zhichao Fu China
Liyuan Wu China
Zhenru Zhu China
Hailong Sheng
Citations per year, relative to Hailong Sheng Hailong Sheng (= 1×) peers Zhenru Zhu

Countries citing papers authored by Hailong Sheng

Since Specialization
Citations

This map shows the geographic impact of Hailong Sheng's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hailong Sheng with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hailong Sheng more than expected).

Fields of papers citing papers by Hailong Sheng

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hailong Sheng. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hailong Sheng. The network helps show where Hailong Sheng may publish in the future.

Co-authorship network of co-authors of Hailong Sheng

This figure shows the co-authorship network connecting the top 25 collaborators of Hailong Sheng. A scholar is included among the top collaborators of Hailong Sheng based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hailong Sheng. Hailong Sheng is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Xu, Shenyuan, et al.. (2025). The role and therapeutic value of NUSAP1 in human cancers. Journal of Translational Medicine. 23(1). 725–725.
2.
Wang, Xiaohua, Yanwei Lu, Ruiqi Liu, et al.. (2025). LZTS2 methylation as a potential diagnostic and prognostic marker in LIHC and STAD: Evidence from bioinformatics and in vitro analyses. Scientific Reports. 15(1). 17873–17873.
3.
Liu, Ruiqi, et al.. (2025). Lactylation-mediated miRNA regulation in cancer therapy resistance. Journal of Translational Medicine. 23(1). 941–941. 1 indexed citations
4.
Liu, Ruiqi, Keke Xu, Xiaohong Chen, et al.. (2025). Branched-chain amino acid and cancer: metabolism, immune microenvironment and therapeutic targets. Journal of Translational Medicine. 23(1). 636–636. 2 indexed citations
5.
Peng, Weiwei, et al.. (2025). Impact of Timing the Combination of Radiotherapy and PD-1 Inhibitors on Outcomes in Patients with Hepatocellular Carcinoma. Journal of Hepatocellular Carcinoma. Volume 12. 123–134.
6.
Chen, Yiyao, Miao Song, Xinrong He, et al.. (2024). Polystyrene microplastics aggravate radiation-induced intestinal injury in mice. Ecotoxicology and Environmental Safety. 283. 116834–116834. 4 indexed citations
7.
Zhao, Jun, et al.. (2024). Detection and quantification of microplastics in various types of human tumor tissues. Ecotoxicology and Environmental Safety. 283. 116818–116818. 32 indexed citations
8.
Sheng, Hailong & Chao Yang. (2022). PFNN-2: A Domain Decomposed Penalty-Free Neural Network Method for Solving Partial Differential Equations. Communications in Computational Physics. 32(4). 980–1006. 11 indexed citations
9.
Wu, Dehua, et al.. (2021). Safety of PD-1/PD-L1 Inhibitors Combined With Palliative Radiotherapy and Anti-Angiogenic Therapy in Advanced Hepatocellular Carcinoma. Frontiers in Oncology. 11. 686621–686621. 32 indexed citations
10.
11.
Sheng, Hailong, Yan Huang, Zhenru Zhu, et al.. (2020). ATR inhibitor AZD6738 enhances the antitumor activity of radiotherapy and immune checkpoint inhibitors by potentiating the tumor immune microenvironment in hepatocellular carcinoma. Journal for ImmunoTherapy of Cancer. 8(1). e000340–e000340. 166 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Zhenru Zhu Breakdown of academic impact, for papers by Liangliang Dong Breakdown of academic impact, for papers by Chunlai Yin Breakdown of academic impact, for papers by Dongzhi Cen Breakdown of academic impact, for papers by Yujie Tan Breakdown of academic impact, for papers by Zhu Zeng Breakdown of academic impact, for papers by Huabin Li Breakdown of academic impact, for papers by Yingpeng Zhao Breakdown of academic impact, for papers by Zhichao Fu Breakdown of academic impact, for papers by Liyuan Wu
Rankless by CCL
2026